[4-[3-[2-[4-(cyclopropanecarbonyl)piperazin-1-yl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]pyridine-3-carbonyl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperazin-1-yl]-cyclopropylmethanone
C51H46F2N14O3S2 — CID 177253092
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[3-[2-[4-(cyclopropanecarbonyl)piperazin-1-yl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]pyridine-3-carbonyl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperazin-1-yl]-cyclopropylmethanone
[4-[3-[2-[4-(cyclopropanecarbonyl)piperazin-1-yl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]pyridine-3-carbonyl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperazin-1-yl]-cyclopropylmethanone (PubChem CID 177253092) has the molecular formula C51H46F2N14O3S2 and a molecular weight of 1005.15 g/mol. Its IUPAC name is [4-[3-[2-[4-(cyclopropanecarbonyl)piperazin-1-yl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]pyridine-3-carbonyl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperazin-1-yl]-cyclopropylmethanone.
Molecular Properties
| Compound Name | [4-[3-[2-[4-(cyclopropanecarbonyl)piperazin-1-yl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]pyridine-3-carbonyl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperazin-1-yl]-cyclopropylmethanone |
|---|---|
| PubChem CID | 177253092 |
| Molecular Formula | C51H46F2N14O3S2 |
| Molecular Weight | 1005.15 g/mol |
| Exact Mass | 1004.33 |
| IUPAC Name | [4-[3-[2-[4-(cyclopropanecarbonyl)piperazin-1-yl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]pyridine-3-carbonyl]-6-[[5-fluoro-4-(2-methyl-1,3-benzothiazol-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperazin-1-yl]-cyclopropylmethanone |
| SMILES | Cc1nc2ccc(-c3nc(Nc4ccc(C(=O)c5ccc(Nc6ncc(F)c(-c7ccc8nc(C)sc8c7)n6)nc5N5CCN(C(=O)C6CC6)CC5)c(N5CCN(C(=O)C6CC6)CC5)n4)ncc3F)cc2s1 |
| InChI | InChI=1S/C51H46F2N14O3S2/c1-27-56-37-11-7-31(23-39(37)71-27)43-35(52)25-54-50(62-43)60-41-13-9-33(46(58-41)64-15-19-66(20-16-64)48(69)29-3-4-29)45(68)34-10-14-42(59-47(34)65-17-21-67(22-18-65)49(70)30-5-6-30)61-51-55-26-36(53)44(63-51)32-8-12-38-40(24-32)72-28(2)57-38/h7-14,23-26,29-30H,3-6,15-22H2,1-2H3,(H,54,58,60,62)(H,55,59,61,63) |
| InChIKey | MMDXMGPCMYLVEU-UHFFFAOYSA-N |
| XLogP | 8.34 |
| TPSA | 191.35 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 72 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1005.15 |
| LogP ≤ 5 | 8.34 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177253092 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.